Cargando…
Methotrexate and TNF inhibitors affect long-term immunogenicity to COVID-19 vaccination in patients with immune-mediated inflammatory disease
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975261/ https://www.ncbi.nlm.nih.gov/pubmed/35403000 http://dx.doi.org/10.1016/S2665-9913(22)00069-8 |
| _version_ | 1784680364113920000 |
|---|---|
| author | Haberman, Rebecca H Um, Seungha Axelrad, Jordan E Blank, Rebecca B Uddin, Zakwan Catron, Sydney Neimann, Andrea L Mulligan, Mark J Herat, Ramin Sedaghat Hong, Simon J Chang, Shannon Myrtaj, Arnold Ghiasian, Ghoncheh Izmirly, Peter M Saxena, Amit Solomon, Gary Azar, Natalie Samuels, Jonathan Golden, Brian D Rackoff, Paula Adhikari, Samrachana Hudesman, David P Scher, Jose U |
| author_facet | Haberman, Rebecca H Um, Seungha Axelrad, Jordan E Blank, Rebecca B Uddin, Zakwan Catron, Sydney Neimann, Andrea L Mulligan, Mark J Herat, Ramin Sedaghat Hong, Simon J Chang, Shannon Myrtaj, Arnold Ghiasian, Ghoncheh Izmirly, Peter M Saxena, Amit Solomon, Gary Azar, Natalie Samuels, Jonathan Golden, Brian D Rackoff, Paula Adhikari, Samrachana Hudesman, David P Scher, Jose U |
| author_sort | Haberman, Rebecca H |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8975261 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89752612022-04-04 Methotrexate and TNF inhibitors affect long-term immunogenicity to COVID-19 vaccination in patients with immune-mediated inflammatory disease Haberman, Rebecca H Um, Seungha Axelrad, Jordan E Blank, Rebecca B Uddin, Zakwan Catron, Sydney Neimann, Andrea L Mulligan, Mark J Herat, Ramin Sedaghat Hong, Simon J Chang, Shannon Myrtaj, Arnold Ghiasian, Ghoncheh Izmirly, Peter M Saxena, Amit Solomon, Gary Azar, Natalie Samuels, Jonathan Golden, Brian D Rackoff, Paula Adhikari, Samrachana Hudesman, David P Scher, Jose U Lancet Rheumatol Comment Elsevier Ltd. 2022-06 2022-04-01 /pmc/articles/PMC8975261/ /pubmed/35403000 http://dx.doi.org/10.1016/S2665-9913(22)00069-8 Text en © 2022 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Comment Haberman, Rebecca H Um, Seungha Axelrad, Jordan E Blank, Rebecca B Uddin, Zakwan Catron, Sydney Neimann, Andrea L Mulligan, Mark J Herat, Ramin Sedaghat Hong, Simon J Chang, Shannon Myrtaj, Arnold Ghiasian, Ghoncheh Izmirly, Peter M Saxena, Amit Solomon, Gary Azar, Natalie Samuels, Jonathan Golden, Brian D Rackoff, Paula Adhikari, Samrachana Hudesman, David P Scher, Jose U Methotrexate and TNF inhibitors affect long-term immunogenicity to COVID-19 vaccination in patients with immune-mediated inflammatory disease |
| title | Methotrexate and TNF inhibitors affect long-term immunogenicity to COVID-19 vaccination in patients with immune-mediated inflammatory disease |
| title_full | Methotrexate and TNF inhibitors affect long-term immunogenicity to COVID-19 vaccination in patients with immune-mediated inflammatory disease |
| title_fullStr | Methotrexate and TNF inhibitors affect long-term immunogenicity to COVID-19 vaccination in patients with immune-mediated inflammatory disease |
| title_full_unstemmed | Methotrexate and TNF inhibitors affect long-term immunogenicity to COVID-19 vaccination in patients with immune-mediated inflammatory disease |
| title_short | Methotrexate and TNF inhibitors affect long-term immunogenicity to COVID-19 vaccination in patients with immune-mediated inflammatory disease |
| title_sort | methotrexate and tnf inhibitors affect long-term immunogenicity to covid-19 vaccination in patients with immune-mediated inflammatory disease |
| topic | Comment |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975261/ https://www.ncbi.nlm.nih.gov/pubmed/35403000 http://dx.doi.org/10.1016/S2665-9913(22)00069-8 |
| work_keys_str_mv | AT habermanrebeccah methotrexateandtnfinhibitorsaffectlongtermimmunogenicitytocovid19vaccinationinpatientswithimmunemediatedinflammatorydisease AT umseungha methotrexateandtnfinhibitorsaffectlongtermimmunogenicitytocovid19vaccinationinpatientswithimmunemediatedinflammatorydisease AT axelradjordane methotrexateandtnfinhibitorsaffectlongtermimmunogenicitytocovid19vaccinationinpatientswithimmunemediatedinflammatorydisease AT blankrebeccab methotrexateandtnfinhibitorsaffectlongtermimmunogenicitytocovid19vaccinationinpatientswithimmunemediatedinflammatorydisease AT uddinzakwan methotrexateandtnfinhibitorsaffectlongtermimmunogenicitytocovid19vaccinationinpatientswithimmunemediatedinflammatorydisease AT catronsydney methotrexateandtnfinhibitorsaffectlongtermimmunogenicitytocovid19vaccinationinpatientswithimmunemediatedinflammatorydisease AT neimannandreal methotrexateandtnfinhibitorsaffectlongtermimmunogenicitytocovid19vaccinationinpatientswithimmunemediatedinflammatorydisease AT mulliganmarkj methotrexateandtnfinhibitorsaffectlongtermimmunogenicitytocovid19vaccinationinpatientswithimmunemediatedinflammatorydisease AT heratraminsedaghat methotrexateandtnfinhibitorsaffectlongtermimmunogenicitytocovid19vaccinationinpatientswithimmunemediatedinflammatorydisease AT hongsimonj methotrexateandtnfinhibitorsaffectlongtermimmunogenicitytocovid19vaccinationinpatientswithimmunemediatedinflammatorydisease AT changshannon methotrexateandtnfinhibitorsaffectlongtermimmunogenicitytocovid19vaccinationinpatientswithimmunemediatedinflammatorydisease AT myrtajarnold methotrexateandtnfinhibitorsaffectlongtermimmunogenicitytocovid19vaccinationinpatientswithimmunemediatedinflammatorydisease AT ghiasianghoncheh methotrexateandtnfinhibitorsaffectlongtermimmunogenicitytocovid19vaccinationinpatientswithimmunemediatedinflammatorydisease AT izmirlypeterm methotrexateandtnfinhibitorsaffectlongtermimmunogenicitytocovid19vaccinationinpatientswithimmunemediatedinflammatorydisease AT saxenaamit methotrexateandtnfinhibitorsaffectlongtermimmunogenicitytocovid19vaccinationinpatientswithimmunemediatedinflammatorydisease AT solomongary methotrexateandtnfinhibitorsaffectlongtermimmunogenicitytocovid19vaccinationinpatientswithimmunemediatedinflammatorydisease AT azarnatalie methotrexateandtnfinhibitorsaffectlongtermimmunogenicitytocovid19vaccinationinpatientswithimmunemediatedinflammatorydisease AT samuelsjonathan methotrexateandtnfinhibitorsaffectlongtermimmunogenicitytocovid19vaccinationinpatientswithimmunemediatedinflammatorydisease AT goldenbriand methotrexateandtnfinhibitorsaffectlongtermimmunogenicitytocovid19vaccinationinpatientswithimmunemediatedinflammatorydisease AT rackoffpaula methotrexateandtnfinhibitorsaffectlongtermimmunogenicitytocovid19vaccinationinpatientswithimmunemediatedinflammatorydisease AT adhikarisamrachana methotrexateandtnfinhibitorsaffectlongtermimmunogenicitytocovid19vaccinationinpatientswithimmunemediatedinflammatorydisease AT hudesmandavidp methotrexateandtnfinhibitorsaffectlongtermimmunogenicitytocovid19vaccinationinpatientswithimmunemediatedinflammatorydisease AT scherjoseu methotrexateandtnfinhibitorsaffectlongtermimmunogenicitytocovid19vaccinationinpatientswithimmunemediatedinflammatorydisease AT methotrexateandtnfinhibitorsaffectlongtermimmunogenicitytocovid19vaccinationinpatientswithimmunemediatedinflammatorydisease |